ArticleHepatology international2022

Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period.

Masaki Kaibori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.